Trials / Unknown
UnknownNCT02398955
Biomime Stent in All-comers PCI Patients Registry
Biomime Biosorbable Polymer Sirolimus-ELuting Stent in alL-comers patIeNts Treated With Percutaneous Coronary Interventions: the BELLINI Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Azienda Ospedaliero Universitaria Maggiore della Carita · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Biomime stent is a novel sirolimus-eluting stent (SES) (Meril Life Sciences Pvt. Ltd., Gujarat, India) with an ultra-thin stent platform (65 μm) and a biodegradable polymer licensed for the treatment of de novo coronary lesions. However no data regarding the efficacy and safety of this stent in an "all-comers" patient population treated with percutaneus coronary interventions (PCI) have been published so far. In this registry the investigators aimed to collect clinical and angiographic information about an extensive "all-comers" employ of this novel stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | percutaneous coronary intervention | percutaneous coronary angioplasty with implantation of at least one Biomime stent |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-12-01
- First posted
- 2015-03-26
- Last updated
- 2015-03-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02398955. Inclusion in this directory is not an endorsement.